SEC Form 4 · accession 0000905718-15-000688
Celldex Therapeutics, Inc. · CLDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anthony S Marucci
Officer — President and CEO · Director
Period of report
Aug 13, 2015
Accepted (ET)
Aug 14, 2015 · 8:01 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000744218
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.001 per shareF1 | Aug 13, 2015 | P | 5,800 | $16.8099 | A | 50,028 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 340 shares of common stock acquired under the Company's 2004 Employee Stock Purchase Plan on June 30, 2015.